ChemicalBook > CAS DataBase List > HLM006474

HLM006474

Product Name
HLM006474
CAS No.
353519-63-8
Chemical Name
HLM006474
Synonyms
CS-1224;HLM006474;E2F Inhibitor, HLM006474 - CAS 353519-63-8 - Calbiochem;HLM006474,inhibit,HLM 006474,Early 2 Factor (E2F),Inhibitor,HLM-006474;7-((4-Ethoxy-3-methylphenyl)(pyridin-2-ylamino)methyl)-2-methylquinolin-8-ol;8-Quinolinol, 7-[(4-ethoxy-3-methylphenyl)(2-pyridinylamino)methyl]-2-methyl-
CBNumber
CB92715640
Molecular Formula
C25H25N3O2
Formula Weight
399.48
MOL File
353519-63-8.mol
More
Less

HLM006474 Property

Boiling point:
588.7±50.0 °C(Predicted)
Density 
1.227±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO:25.0(Max Conc. mg/mL);62.58(Max Conc. mM)
form 
Off-white solid
pka
4.36±0.50(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H413May cause long lasting harmful effects to aquatic life

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML1260
Product name
HLM006474
Purity
≥98% (HPLC)
Packaging
5MG
Price
$118
Updated
2024/03/01
Sigma-Aldrich
Product number
SML1260
Product name
HLM006474
Purity
≥98% (HPLC)
Packaging
25MG
Price
$462
Updated
2024/03/01
Sigma-Aldrich
Product number
324461
Product name
E2F Inhibitor, HLM006474 - CAS 353519-63-8 - Calbiochem<br />The E2F Inhibitor, HLM006474, also referenced under CAS 353519-63-8, controls the biological activity of E2F. This small molecule/inhibitor is primarily used for Cancer applications.
Packaging
10mg
Price
$182
Updated
2024/03/01
Cayman Chemical
Product number
28276
Product name
HLM006474
Packaging
5mg
Price
$68
Updated
2024/03/01
Cayman Chemical
Product number
28276
Product name
HLM006474
Packaging
10mg
Price
$121
Updated
2024/03/01
More
Less

HLM006474 Chemical Properties,Usage,Production

Description

HLM006474 is a non-selective inhibitor of the transcription factor E2F (IC50 = 29.8 μM for E2F4). It inhibits DNA binding to E2F1, E2F2, and E2F4 in A375 melanoma cells when used at a concentration of 40 μM. HLM006474 (40 μM) decreases protein levels of E2F4 and cyclin D3 and induces apoptosis in A375 cells. It also induces apoptosis in MDA-MB-231, but not MCF-7, cells and inhibits the growth of cancer cells in a panel of 17 lung cancer cell lines (IC50s = 15.5-75.1 μM). HLM006474 reduces tumor growth in retinoblastoma-prone Chx10Cre;Rbfl/fl;p107-/- mice and in an A375 mouse xenograft model when administered at a dose of 100 mg/kg and 2 mg per mouse, respectively.

Uses

HLM006474 has been used as an E2 factor?(E2F) inhibitor in human nasopharyngeal carcinoma hone-1 cells and T. annulata-infected TBL20 cells.

Uses

HLM 006474 acts as an E2F transcription factor inhibitor, preventing DNA binding activity. This results in the induction of apoptosis in breast cancer cells.

General Description

A cell-permeable 8-hydroxyquinoline compound that is reported to inhibit nuclear E2F complexes DNA binding activity (IC50 = 30 μM) and downregulate E2F expression in the melanoma cell line A375, resulting in eventual apoptosis induction without upregulating p53 expression as commonly seen with traditional chemotherapeutic agents, such as Cisplatin (Cat. No. 232120), doxorubicin (Cat. No. 324380), and VP-16 (Cat. No. 341205).

Biochem/physiol Actions

HLM006474 is a pan-E2F transcription factor inhibitor. E2F s part of the CDK/Rb/E2F pathway. When phosphorylated by CDKs, the tumor suppressor retinoblastoma protein (Rb) is inactivated, releasing E2Fs and allowing cell cycle progression. HLM006474 inhibited DNA-binding of all E2F complexes and down-regulated expression of E2F4 protein. HLM006474 induced apoptosis of A375 melanoma cells and synergized with paclitaxel in lung cancer cell lines.

HLM006474 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

HLM006474 Suppliers

Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7553
Advantage
61
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4863
Advantage
58
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51471
Advantage
80
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4153
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9254
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9709
Advantage
58
ShangHai Biochempartner Co.,Ltd
Tel
17754423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8012
Advantage
62
Shanghai Rechem science Co., Ltd.
Tel
21-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2985
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
QQ:65489617 15618227136
Fax
21-5161 9052
Email
info@SuperLan-chem.com
Country
China
ProdList
9747
Advantage
58

353519-63-8, HLM006474Related Search:


  • HLM006474
  • E2F Inhibitor, HLM006474 - CAS 353519-63-8 - Calbiochem
  • CS-1224
  • 8-Quinolinol, 7-[(4-ethoxy-3-methylphenyl)(2-pyridinylamino)methyl]-2-methyl-
  • 7-((4-Ethoxy-3-methylphenyl)(pyridin-2-ylamino)methyl)-2-methylquinolin-8-ol
  • HLM006474,inhibit,HLM 006474,Early 2 Factor (E2F),Inhibitor,HLM-006474
  • 353519-63-8